title: Is there risk of stroke with aflibercept?
authors.affiliation: Retina and Vitreous Centre, Sydney, Australia.
authors.forename: Paul E
authors.initials: PE
authors.lastname: Beaumont
authors.affiliation: Department of Statistics, Faculty of Science, Macquarie University, Sydney, Australia.
authors.forename: Peter
authors.initials: P
authors.lastname: Petocz
authors.affiliation: Retina and Vitreous Centre, Sydney, Australia.
authors.forename: Hyong K
authors.initials: HK
authors.lastname: Kang
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D057135:Wet Macular Degeneration / Q000188:drug therapy*
chemical_list: D011993:Recombinant Fusion Proteins